For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Substance Use Disorder Therapeutics as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment
- Synthetic opioid receptor agonists (buprenorphine; methadone; others)
- Opioid antagonists (naltrexone; naloxone; others)
Companies Covered
- BioXcel
- Opiant
- Intra-Cellular Therapies
- ATAI Life Sciences
- Kona Gold Beverage
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- BioXcel
- Opiant
- Intra-Cellular Therapies
- ATAI Life Sciences
- Kona Gold Beverage

